Gesundheitsverbund, Klinik Floridsdorf
Welcome,         Profile    Billing    Logout  
 12 Trials 
15 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Valipour, Arschang
BLOC, NCT05911009 / 2022-003452-14: To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID

Completed
2
119
Europe
BC 007 or matching placebo
Berlin Cures GmbH, Berlin Cures GmbH
Long Covid
06/24
09/24
NCT06035120: An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients with Severe Emphysema

Recruiting
N/A
200
Europe, US, RoW
AeriSeal System
Pulmonx Corporation
Emphysema, Pulmonary, Emphysema or COPD
06/27
03/28
NCT06522334: Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria

Recruiting
N/A
400
Europe
Ludwig Boltzmann Institute for Lung Health
Interstitial Lung Disease
02/34
02/34
RheSolve, NCT04677465: Clinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic Bronchitis

Active, not recruiting
N/A
270
Europe, US
RheOx Bronchial Rheoplasty, Sham Procedure
Gala Therapeutics, Inc.
Chronic Bronchitis
05/24
10/25
AIRFLOW-3, NCT03639051: Evaluation of the Safety and Efficacy of TLD in Patients with COPD

Active, not recruiting
N/A
464
Europe, US
Targeted Lung Denervation (TLD), TLD, TLD Therapy, Optimal Medical Care
Nuvaira, Inc.
COPD
10/24
09/28
NCT04182841: RheOx Registry Study in Europe

Recruiting
N/A
100
Europe
RheOx
Gala Therapeutics, Inc.
Chronic Bronchitis, COPD
12/24
12/25
NCT06655428: The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema

Recruiting
N/A
30
Europe
Endobronchial Therman Liquid Ablation (ETLA), Bronchoscopic lung volume reduction
Morair Medtech, LLC
Emphysema or COPD, Emphysema, Emphysema, Pulmonary, COPD, COPD (Chronic Obstructive Pulmonary Disease)
02/26
05/26
BREATHE-2, NCT05949645: Study to Assess Safety, Feasibility, and Preliminary Efficacy of the Apreo Implant for Severe Emphysema

Active, not recruiting
N/A
30
Europe
Apreo Implant Group
Apreo Health, Inc.
Emphysema or COPD
10/24
06/26
NCT03318406: Post-Market BTVA Registry

Recruiting
N/A
300
Europe
Bronchoscopic Thermal Vapor Ablation, BTVA, InterVapor
Uptake Medical Technology, Inc.
Emphysema or COPD
12/27
12/30
VAPORIZED, NCT03514329: Vapor Ablation for Localized Cancer Lesions

Not yet recruiting
N/A
10
Europe
Bronchoscopic Thermal Vapor Ablation, BTVA-C
Uptake Medical Technology, Inc.
Non Small Cell Lung Cancer, Metastatic Lung Cancer, Lung Cancer
03/28
06/28
Funk, Georg-Christian
ACOVACT, NCT04351724 / 2020-001302-30: Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)

Recruiting
2/3
500
Europe
Chloroquine or Hydroxychloroquine, Lopinavir/Ritonavir, Best standard of care, Rivaroxaban, Thromboprophylaxis, Candesartan, non-RAS blocking antihypertensives, Remdesivir, Asunercept 400mg, Asunercept 100mg, Asunercept 25mg, Pentaglobin
Medical University of Vienna, Kaiser Franz Josef Hospital, SMZ-Ost Donauspital, Otto Wagner Hospital, Hospital Hietzing, Wilhelminenspital Vienna, Medical University Innsbruck, Medical University of Graz, Kepler University Hospital
COVID-19
12/21
03/22
SPIROMIND, NCT04769505: Mindfulness-based Interventions in COPD Patients

Completed
N/A
30
Europe
digital mindfulness-based intervention (MBI)
Karl Landsteiner Institute for Lung Research and Pneumological Oncology, University of Vienna, Klinik Ottakring, Klinik Floridsdorf, Therme Wien Med (Ambulant Pulmonary Rehabilitation)
Chronic Obstructive Pulmonary Disease Exacerbation
12/22
03/23
NCT04819477: Can Austrian Lung Specialists' Assessments of Lung Cancer Screening be Influenced by a Fact Box?"

Completed
N/A
973
Europe
Fact box, Cates plot
Karl Landsteiner Institute for Lung Research and Pneumological Oncology
Lung Cancer
10/21
10/21
NCT06522334: Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria

Recruiting
N/A
400
Europe
Ludwig Boltzmann Institute for Lung Health
Interstitial Lung Disease
02/34
02/34
LALUCA, NCT04733430: Research Platform A Prospective Analysis of Lung Cancer Diagnosis and Management in Clinical Practice

Recruiting
N/A
500
Europe
Karl Landsteiner Institute for Lung Research and Pneumological Oncology
Lung Cancer
04/30
04/30
Hoeppler, Wolfgang
No trials found
Hussain, Saad
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Valipour, Arschang
BLOC, NCT05911009 / 2022-003452-14: To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID

Completed
2
119
Europe
BC 007 or matching placebo
Berlin Cures GmbH, Berlin Cures GmbH
Long Covid
06/24
09/24
NCT06035120: An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients with Severe Emphysema

Recruiting
N/A
200
Europe, US, RoW
AeriSeal System
Pulmonx Corporation
Emphysema, Pulmonary, Emphysema or COPD
06/27
03/28
NCT06522334: Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria

Recruiting
N/A
400
Europe
Ludwig Boltzmann Institute for Lung Health
Interstitial Lung Disease
02/34
02/34
RheSolve, NCT04677465: Clinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic Bronchitis

Active, not recruiting
N/A
270
Europe, US
RheOx Bronchial Rheoplasty, Sham Procedure
Gala Therapeutics, Inc.
Chronic Bronchitis
05/24
10/25
AIRFLOW-3, NCT03639051: Evaluation of the Safety and Efficacy of TLD in Patients with COPD

Active, not recruiting
N/A
464
Europe, US
Targeted Lung Denervation (TLD), TLD, TLD Therapy, Optimal Medical Care
Nuvaira, Inc.
COPD
10/24
09/28
NCT04182841: RheOx Registry Study in Europe

Recruiting
N/A
100
Europe
RheOx
Gala Therapeutics, Inc.
Chronic Bronchitis, COPD
12/24
12/25
NCT06655428: The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema

Recruiting
N/A
30
Europe
Endobronchial Therman Liquid Ablation (ETLA), Bronchoscopic lung volume reduction
Morair Medtech, LLC
Emphysema or COPD, Emphysema, Emphysema, Pulmonary, COPD, COPD (Chronic Obstructive Pulmonary Disease)
02/26
05/26
BREATHE-2, NCT05949645: Study to Assess Safety, Feasibility, and Preliminary Efficacy of the Apreo Implant for Severe Emphysema

Active, not recruiting
N/A
30
Europe
Apreo Implant Group
Apreo Health, Inc.
Emphysema or COPD
10/24
06/26
NCT03318406: Post-Market BTVA Registry

Recruiting
N/A
300
Europe
Bronchoscopic Thermal Vapor Ablation, BTVA, InterVapor
Uptake Medical Technology, Inc.
Emphysema or COPD
12/27
12/30
VAPORIZED, NCT03514329: Vapor Ablation for Localized Cancer Lesions

Not yet recruiting
N/A
10
Europe
Bronchoscopic Thermal Vapor Ablation, BTVA-C
Uptake Medical Technology, Inc.
Non Small Cell Lung Cancer, Metastatic Lung Cancer, Lung Cancer
03/28
06/28
Funk, Georg-Christian
ACOVACT, NCT04351724 / 2020-001302-30: Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)

Recruiting
2/3
500
Europe
Chloroquine or Hydroxychloroquine, Lopinavir/Ritonavir, Best standard of care, Rivaroxaban, Thromboprophylaxis, Candesartan, non-RAS blocking antihypertensives, Remdesivir, Asunercept 400mg, Asunercept 100mg, Asunercept 25mg, Pentaglobin
Medical University of Vienna, Kaiser Franz Josef Hospital, SMZ-Ost Donauspital, Otto Wagner Hospital, Hospital Hietzing, Wilhelminenspital Vienna, Medical University Innsbruck, Medical University of Graz, Kepler University Hospital
COVID-19
12/21
03/22
SPIROMIND, NCT04769505: Mindfulness-based Interventions in COPD Patients

Completed
N/A
30
Europe
digital mindfulness-based intervention (MBI)
Karl Landsteiner Institute for Lung Research and Pneumological Oncology, University of Vienna, Klinik Ottakring, Klinik Floridsdorf, Therme Wien Med (Ambulant Pulmonary Rehabilitation)
Chronic Obstructive Pulmonary Disease Exacerbation
12/22
03/23
NCT04819477: Can Austrian Lung Specialists' Assessments of Lung Cancer Screening be Influenced by a Fact Box?"

Completed
N/A
973
Europe
Fact box, Cates plot
Karl Landsteiner Institute for Lung Research and Pneumological Oncology
Lung Cancer
10/21
10/21
NCT06522334: Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria

Recruiting
N/A
400
Europe
Ludwig Boltzmann Institute for Lung Health
Interstitial Lung Disease
02/34
02/34
LALUCA, NCT04733430: Research Platform A Prospective Analysis of Lung Cancer Diagnosis and Management in Clinical Practice

Recruiting
N/A
500
Europe
Karl Landsteiner Institute for Lung Research and Pneumological Oncology
Lung Cancer
04/30
04/30
Hoeppler, Wolfgang
No trials found
Hussain, Saad
No trials found

Download Options